Track topics on Twitter Track topics that are important to you
Global law firm Greenberg Traurig, LLP’s Life Sciences & Medical Technology Group co-hosted a Medical Devices Market Trends & Opportunities Educational Breakfast with engineering and scientific consulting firm Exponent. The event was held Nov. 12 in the firm’s Boston office.
BOSTON (PRWEB) November 13, 2019
Global law firm Greenberg Traurig, LLP’s Life Sciences & Medical Technology Group co-hosted a Medical Devices Market Trends & Opportunities Educational Breakfast with engineering and scientific consulting firm Exponent. The event was held Nov. 12 in the firm’s Boston office. The event addressed trends in the medtech industry, identified opportunities for innovators to develop intellectual property (IP), examined energy and power management for medical devices, and discussed the requirements and constraints that originate from patients, physicians, and regulatory agencies.
From 8:00 – 9:30 a.m., David J. Dykeman, patent attorney and co-chair of Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group and Boston Intellectual Property & Technology Group, was a panelist. He was joined by David Borsook, MD, Ph.D., Professor, Harvard Medical School; Geoff DaCosta, Director of Business Development & Licensing, Medtronic; and Alex Margulis, Ph.D., Chief Operating Officer, Mansfield Bio-Incubator. From 9:45 – 10:30 a.m., presentations were made by Exponent Principal Quinn C. Horn, Ph.D., P.E., and Senior Associate Sergio Mendoza, Ph.D. Chinh H. Pham, chair of Greenberg Traurig’s Emerging Technology Group and co-chair of the firm’s Boston IP Group, gave welcome remarks.
Exponent is a global engineering and scientific consulting firm that brings together more than 90 different disciplines to address complex issues facing industry and government today. For over 50 years, Exponent has provided engineering, scientific, environmental and health consulting services to corporations, insurance carriers, government agencies, law firms, and individuals. The firm is best known for analyzing accidents and failures to determine their causes, as well as assisting clients with human health, environmental, engineering and regulatory issues associated with new products or processes to help prevent problems in the future.
About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig’s Boston Office: Established in 1999, Greenberg Traurig’s Boston office is home to over 70 attorneys practicing in the areas of bankruptcy, business aviation, corporate, emerging technology, energy, gaming, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, and real estate. An important contributor to the firm's international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of legal experience and hands-on knowledge of the local business community, supported by the firm's vast network of global resources.
About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2100 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law
For the original version on PRWeb visit: https://www.prweb.com/releases/greenberg_traurigs_boston_office_hosts_medical_devices_market_trends_opportunities_breakfast/prweb16722404.htmNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...